Durham, NC, United States of America

Stephen V Frye


Average Co-Inventor Count = 2.8

ph-index = 6

Forward Citations = 146(Granted Patents)


Company Filing History:


Years Active: 1991-2006

Loading Chart...
15 patents (USPTO):

Title: **Innovative Contributions of Stephen V. Frye**

Introduction

Stephen V. Frye is a notable inventor based in Durham, NC, recognized for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 15 patents, he has demonstrated a strong commitment to advancing medical science, particularly in the area of cancer treatment.

Latest Patents

Frye's groundbreaking latest patents include "Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors" and "Compositions and methods of treating chemotherapy and radiation therapy side effects." These innovations focus on compounds designed to assist in the treatment of diseases mediated by CDK2 activity, which is particularly relevant for addressing alopecia induced by cancer chemotherapy or radiotherapy. The intricate formulas involve various derivatives that have the potential to significantly improve therapeutic outcomes for patients undergoing such treatments.

Career Highlights

Stephen V. Frye has worked with prominent companies such as Glaxo Wellcome Inc. and Glaxo Inc., where he applied his expertise in medicinal chemistry to develop new therapeutic agents. His career reflects a consistent dedication to innovation, aiming to enhance the effectiveness of treatments in the medical field.

Collaborations

Throughout his career, Frye has had the opportunity to collaborate with esteemed colleagues, including Kenneth William Batchelor and Stephen Thomas Davis. These collaborations have contributed to the development of cutting-edge solutions in pharmacology, further solidifying Frye's reputation as a key figure in medicinal invention.

Conclusion

Stephen V. Frye exemplifies the essence of innovation in the realm of patents and pharmaceuticals. His inventions not only highlight his expertise but also hold the promise of impacting the lives of patients facing the challenges of cancer treatments. With a continued focus on development and collaboration, Frye's contributions will likely remain influential in future advancements within the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…